Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.
about
Implications of Insulin-like Growth Factor 1 Receptor Activation in Lung CancerIGF-IR: a new prognostic biomarker for human glioblastomaMolecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor I receptor inhibitionOptical fiber-based in vivo quantification of growth factor receptors.Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer.Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptorBiomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancerNovel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma.The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.Genomic and molecular characterization of malignant peripheral nerve sheath tumor identifies the IGF1R pathway as a primary target for treatment.Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls.Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer.BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549.Mutational analysis of the insulin-like growth factor 1 receptor tyrosine kinase domain in non-small cell lung cancer patients.Membranous Insulin-like Growth Factor-1 Receptor (IGF1R) Expression Is Predictive of Poor Prognosis in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Lung AdenocarcinomaGenetic changes in squamous cell lung cancer: a reviewActivation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer.Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer.Automated tumor analysis for molecular profiling in lung cancer.Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated With Penile Cancer Progression.ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer.AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth.Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients.Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric CancerErlotinib: as maintenance monotherapy in non-small-cell lung cancer.Receptor tyrosine kinase alterations and therapeutic opportunities in squamous cell carcinoma of the lung.Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas.Insulin-like Growth Factor 1 Receptor Expression in Advanced Non-small-cell Lung Cancer and its Impact on Overall Survival.Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.Insulin-like growth factor receptor-1 expression predicts postoperative recurrence in adenocarcinoma of the lung.The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancerIGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance.Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer.Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.The role of epithelial-mesenchymal transition and IGF-1R expression in prediction of gefitinib activity as the second-line treatment for advanced nonsmall-cell lung cancer.Tumor suppression function of FoxD3 in lung cancer.Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression.Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer.Expression of IGF1R is associated with tumor differentiation and survival in patients with lung adenocarcinoma.
P2860
Q26740210-8FD2C66F-0351-4D9F-A3FC-26CC2059D97AQ30375102-66BA72E9-06CF-4E33-9CBD-09C8C6E73C8FQ34187898-D00C78D6-91E5-4E68-AB93-A65B76FC95D4Q34226408-8CE5F80E-FFD8-4504-A74B-CE0FBE348369Q34501591-9B414804-B85E-48DB-952D-93C74C2856E8Q34568232-9F95C4B0-B530-4D63-ADD3-B041BECFB5DEQ34796287-56BEB503-78AA-48C0-8E04-68069E2968F5Q35108419-9092E527-99DB-49A0-88E3-8E44921B4B19Q35156742-AF0BDF8F-2CD4-4310-93A8-723318A3ED98Q35568803-D1E249CC-BF14-4F63-96D0-56B20543BB6EQ35627023-9D79D09B-885E-4DDA-B100-89DD07B4CBC6Q35810171-24291072-A07B-4BB1-9E66-37BF259FFBB3Q35819793-5E67CF9F-6095-44F7-8655-FF25028213A8Q35940305-CA29CCF2-E90F-4B2B-A33B-EAACE09AB5A4Q35948040-944CBA4D-FF31-4456-ABFC-DEB92DBB68E3Q36084143-F9005DF0-E419-4D47-B681-E19B5C7C73E3Q36115735-18960888-2F5F-42AA-A0B2-40E745733D30Q36140955-938548BE-8DEB-49F7-AA44-5F6AC696589FQ36224160-C5B09EDF-C6F2-4910-BD2A-E19EB5340EB5Q36413949-655519CB-C749-4759-844A-2EBAC188B805Q36922072-F03EA7A2-24E4-4ECC-BE0A-C36084398BA0Q36980480-BC90EA17-59F6-4E66-934E-5E6A1BDE9242Q37565415-621F4AB3-60C1-452A-9C03-5D4B7FA26F5AQ37657511-6435F473-E127-4CF4-BF41-D60B6CCA2AECQ37660522-0B4777D7-D7EE-42E8-9AF9-4BA78FD2C73BQ37868006-C8D51E35-27BB-4521-B129-ED1C9156459EQ38130137-901F9CDF-AF34-4AA7-BDB0-0AEC652AE3ECQ38395821-CF114FF7-0926-49C2-8F0F-EFAF975B8EBBQ38663388-AD0EF435-6551-4B75-AE34-10883C06EEB4Q39098768-C3CCA253-77D6-4005-AE32-207E366CAE29Q42160729-6E97C949-2957-4C5F-8EB0-6B0AA25EBF4EQ42337044-A2D53784-1A13-4FA9-8C34-9A39DCB71D50Q44518083-1D3699D4-2DA5-46A1-A2D5-4AEFD5335FC4Q44636888-3F0A38E3-F6BB-427B-A2BE-9A8203FB4857Q44645468-6226AF62-B1B7-4780-B7B8-76A8EF007105Q46564163-7BAF126C-E564-4772-A877-A0A9D2BB7C5FQ52949999-CECBE3F2-3F19-410D-B90F-46D8F2B5D3E3Q53525637-51C65291-F5E3-4059-AE7D-05E6C45446DBQ54331204-2DC99005-F860-44FA-B1FC-F089B9B8A485Q54361164-E089F1A1-606D-4AD7-BDF8-DE9A8FCD4796
P2860
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Insulin-like growth factor rec ...... lung cancer (NSCLC) patients.
@ast
Insulin-like growth factor rec ...... lung cancer (NSCLC) patients.
@en
type
label
Insulin-like growth factor rec ...... lung cancer (NSCLC) patients.
@ast
Insulin-like growth factor rec ...... lung cancer (NSCLC) patients.
@en
prefLabel
Insulin-like growth factor rec ...... lung cancer (NSCLC) patients.
@ast
Insulin-like growth factor rec ...... lung cancer (NSCLC) patients.
@en
P2093
P2860
P50
P356
P1433
P1476
Insulin-like growth factor rec ...... l lung cancer (NSCLC) patients
@en
P2093
G Finocchiaro
L Terracciano
M Alloisio
M Incarbone
M Varella-Garcia
R S Wilson
P2860
P304
P356
10.1093/ANNONC/MDP357
P577
2009-09-18T00:00:00Z